INVO News and Press, INVO BioScience Inc. From 08/15/22

INVO BioScience press release ( NASDAQ: INVO ): Q2 GAAP EPS of -$0.23 beats by $0.01 . Revenue of $0.14M (-33.3% Y/Y) misses by $0.19M . As of June 30, 2022, the Company had approximately $2.0 million in cash. For further details see: INVO BioScience ...

INVO Bioscience Reports Second Quarter 2022 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , Aug. 15, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a c...

INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , Aug. 4, 2022 /PRNewswire...

INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment PR Newswire Mark Your Calendars for July 7, 2022 , with Dr. Sue Ellen Carpenter of Atlanta -based Bloom Fertility ...

Gainers: DLocal Limited (DLO) +24%. Kidpik (PIK) +21%. GreenBox (GBOX) +19%. Sunlands Technology Group (STG) +17%. TDCX (TDCX) +15%. Magnachip Semiconductor (MX) +14%. Concert Pharmaceuticals (CNCE) +13%. Agilysys (AGYS) +13%. Youdao (DAO) +12%. Losers: Endo International plc (ENDP) -53%. Bau...

INVO Bioscience, Inc. (INVO) Q1 2022 Earnings Conference Call May 16, 2022, 04:30 PM ET Company Participants Robert Blum - Lytham Partners, LLC, IR Steven Shum - CEO Michael Campbell - COO and VP, Business Development Andrea Goren - CFO Conference Call Participants John Heerdink - Vista Partn...

INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China PR Newswire Agreement includes minimum purchase obligations upon product registration and approval SARASOTA, Fla. , May 16, 2022 /PRNewswire/ -- INVO Bioscience, ...

INVO BioScience press release (NASDAQ:INVO): Q1 GAAP EPS of -$0.23 beats by $0.02. Revenue of $0.16M (-76.5% Y/Y) beats by $0.06M. For further details see: INVO BioScience GAAP EPS of -$0.23 beats by $0.02, revenue of $0.16M beats by $0.06M

INVO Bioscience Reports First Quarter 2022 Financial Results PR Newswire Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla. , May 16, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commer...

INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 PR Newswire Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla. , May 9, 2022 /PRNewswire/ -...